How Does Vagus Nerve Stimulation Affect Blood Glucose, Food, and Movement Cravings?
Withdrawn before enrolling · Not applicable · Has a placebo group
Conditions studied: Vagus Nerve Stimulation
In brief
The purpose of this study is to determine the feasibility of using non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) to examine physiological and psychological responses in a college-aged healthy population
Key facts
- Study ID
- NCT07457372
- Run by
- University of Minnesota
- People needed
- 0
- Starts
- 2026-09-01
- Expected to finish
- 2028-05-01
- Last updated by the study team
- 2026-07-20
Who can join
Age: 18 and older, up to 35. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Participants must be between the ages of 18 and 35 as we are focused on recruiting undergraduate and graduate students.
You may not qualify if…
- Participants will be excluded if they have epilepsy, clinically significant tachycardia or arrhythmia, diabetes (Type 1 or Type 2) or another metabolic disease, current pregnancy, any implanted electronic medical device (for example, pacemaker or defibrillator), or a known skin allergy to adhesives that would prevent CGM placement. Participants will also be excluded if they have a history of major depressive disorder if taVNS could reasonably be expected to alter mood symptoms
Where it is running
- University of Minnesota Duluth — Duluth, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.